Breaking down KRAS: small-molecule degraders for cancer therapy

被引：0
|
作者：
Kos, Tina [1 ,2 ,3 ,4 ,5 ]
Saur, Dieter [1 ,2 ,3 ,4 ,5 ,6 ]
机构：
[1] Tech Univ Munich, Chair Translat Canc Res, Sch Med, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
[2] Tech Univ Munich, Inst Expt Canc Therapy, Ismaninger Str 22, D-81675 Munich, Germany
[3] German Canc Res Ctr, Div Translat Canc Res, Neuenheim Feld 280, D-69120 Heidelberg, Germany
[4] German Canc Consortium DKTK, Neuenheim Feld 280, D-69120 Heidelberg, Germany
[5] Tech Univ Munich, Sch Med, Ctr Translat Canc Res TranslaTUM, Einsteinstr 25, D-81675 Munich, Germany
[6] Tech Univ Munich, Dept Internal Med 2, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2025年 / 10卷 / 01期
关键词：
D O I：
10.1038/s41392-025-02172-4
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Targeting cancer with small-molecule pan-KRAS degraders
    Popow, Johannes
    Farnaby, William
    Gollner, Andreas
    Kofink, Christiane
    Fischer, Gerhard
    Wurm, Melanie
    Zollman, David
    Wijaya, Andre
    Mischerikow, Nikolai
    Hasenoehrl, Carina
    Prokofeva, Polina
    Arnhof, Heribert
    Arce-Solano, Silvia
    Bell, Sammy
    Boeck, Georg
    Diers, Emelyne
    Frost, Aileen B.
    Goodwin-Tindall, Jake
    Karolyi-Oezguer, Jale
    Khan, Shakil
    Klawatsch, Theresa
    Koegl, Manfred
    Kousek, Roland
    Kratochvil, Barbara
    Kropatsch, Katrin
    Lauber, Arnel A.
    Mclennan, Ross
    Olt, Sabine
    Peter, Daniel
    Petermann, Oliver
    Roessler, Vanessa
    Stolt-Bergner, Peggy
    Strack, Patrick
    Strauss, Eva
    Trainor, Nicole
    Vetma, Vesna
    Whitworth, Claire
    Zhong, Siying
    Quant, Jens
    Weinstabl, Harald
    Kuster, Bernhard
    Ettmayer, Peter
    Ciulli, Alessio
    SCIENCE, 2024, 385 (6715) : 1338 - 1347
  • [2] Small-Molecule Inhibitors and Degraders Targeting KRAS-Driven Cancers
    Hyun, Soonsil
    Shin, Dongyun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [3] A strategy for small-molecule RNA degraders
    Alex Eccleston
    Nature Reviews Drug Discovery, 2023, 22 : 621 - 621
  • [4] A strategy for small-molecule RNA degraders
    Eccleston, Alex
    NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (08) : 621 - 621
  • [5] PROTAC small-molecule degraders of AR protein
    Han, Xin
    Wang, Chao
    Qin, Chong
    Xiang, Weiguo
    Fernandez-Salas, Ester
    Yang, Chao-Yie
    Wang, Mi
    Zhao, Lijie
    Xu, Tianfeng
    Stuckey, Jeanne
    Wang, Shaomeng
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [6] Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy:advances and perspectives
    Yuan Fang
    Guochao Liao
    Bin Yu
    ActaPharmaceuticaSinicaB, 2020, 10 (07) : 1253 - 1278
  • [7] Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
    Fang, Yuan
    Liao, Guochao
    Yu, Bin
    ACTA PHARMACEUTICA SINICA B, 2020, 10 (07) : 1253 - 1278
  • [8] Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
    Ke Xu
    Dongkyoo Park
    Andrew T. Magis
    Jun Zhang
    Wei Zhou
    Gabriel L. Sica
    Suresh S. Ramalingam
    Walter J. Curran
    Xingming Deng
    Molecular Cancer, 18
  • [9] Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
    Xu, Ke
    Park, Dongkyoo
    Magis, Andrew T.
    Zhang, Jun
    Zhou, Wei
    Sica, Gabriel L.
    Ramalingam, Suresh S.
    Curran, Walter J.
    Deng, Xingming
    MOLECULAR CANCER, 2019, 18 (1)
  • [10] Small-molecule bromodomain inhibitors for cancer therapy
    Qi, Jun
    Filippakopoulos, Panagis
    Picaud, Sarah
    Smith, William
    Keates, Tracy
    Morse, Elizabeth
    Philpott, Martin
    Shaw, Katharin
    Fedorov, Oleg
    West, Nathan
    Heightman, Tom
    French, Christopher
    Knapp, Stefan
    Bradner, James
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
12345